Enwei Pharmaceutical Co., Ltd.

SZSE:301331 Stock Report

Market Cap: CN¥2.3b

Enwei Pharmaceutical Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 301331?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders583,9280.585%
Institutions3,575,1613.58%
General Public20,281,88220.3%
Private Companies75,440,20375.5%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 79.69% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
29.8%
Chengdu Enwei Investment (Group) Co., Ltd.
29,733,200CN¥694.9m0%no data
12.9%
Chengdu Zehong Enterprise Management Co., Ltd.
12,884,140CN¥301.1m0%no data
12.9%
Chengdu Ruijinheng Enterprise Management Co., Ltd.
12,884,140CN¥301.1m0%no data
12.9%
Chengdu Jiewei Enterprise Management Co., Ltd.
12,884,140CN¥301.1m0%no data
1.41%
Changdu Jieweite Enterprise Management Co., Ltd.
1,404,564CN¥32.8m0%no data
1.27%
Changdu Longwei Enterprise Management Partnership Enterprise (Limited Partnership)
1,264,912CN¥29.6m0%no data
1.14%
Changdu Xiangwei Enterprise Management Partnership Enterprise (Limited Partnership)
1,134,006CN¥26.5m0%no data
0.89%
Changdu Changwei Enterprise Management Partnership (Limited Partnership)
884,418CN¥20.7m0%no data
0.86%
CITIC Securities Investment Ltd.
863,630CN¥20.2m0%0.62%
0.86%
Changdu Jiwei Enterprise Management Partnership Enterprise (Limited Partnership)
856,480CN¥20.0m-7.56%no data
0.83%
Changdu Huiwei Enterprise Management Partnership Enterprise (Limited Partnership)
830,620CN¥19.4m0%no data
0.68%
Changdu Shengwei Enterprise Management Partnership Enterprise (Limited Partnership)
679,583CN¥15.9m0%no data
0.67%
Tibet Wintour Investment Fund Management Co., Ltd.
670,372CN¥15.7m1.82%no data
0.58%
Li Yi
583,928CN¥13.6m0%no data
0.47%
Gold Stone Investment Co., Ltd.
466,389CN¥10.9m0%0.37%
0.41%
Everbright Asset Management Co., Ltd.
409,828CN¥9.6m0%0.12%
0.34%
Xiaoying Capital Co.,Ltd
341,428CN¥8.0m0%13.66%
0.31%
CITIC Securities Company Limited, Asset Management Arm
308,137CN¥7.2m0%0.01%
0.18%
China Universal Asset Management Company Ltd.
179,336CN¥4.2m0%no data
0.12%
Shanghai Guotai Junan Securities Asset Management Co., Ltd.
119,880CN¥2.8m0%0.01%
0.1%
Golden Trust SinoPac Fund Management Co., Ltd.
104,073CN¥2.4m0%0.02%
0.064%
Penghua Fund Management Co., Ltd.
64,300CN¥1.5m0%no data
0.037%
Jinxin Fund Management Co., Ltd.
37,000CN¥864.6k0%0.02%
0.01%
Broad Asset Management Co., Ltd
10,200CN¥238.3k0%no data
0.00034%
Harvest Fund Management Co. Ltd.
344CN¥7.9k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/25 02:37
End of Day Share Price 2024/12/25 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Enwei Pharmaceutical Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution